IL6 and Hypertension: Therefore, the increases in pro-inflammatory and inflammatory cytokines such as IL-1β, IL-6, and IL-8 in monocytes lead to systemic inflammation and worsen metabolic syndrome, including hypertension in SAS patients (Figure 6).